Coherus BioSciences (CHRS) Reports Q1 Loss Per Share of $1.22
Tweet
Share
E-mailGet Alerts CHRS Hot Sheet
Price: $1.18 +0.85%
Financial Fact:
Income/(loss) from operations: 27.38M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income/(loss) from operations: 27.38M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Coherus BioSciences (NASDAQ: CHRS) reported Q1 EPS of ($1.22), versus ($6.03) reported last year.
For earnings history and earnings-related data on Coherus BioSciences (CHRS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- SPAR Group (SGRP) Reports Q2 EPS of $0.04
- Range Impact, Inc. (RNGE) Reports Q2 Loss of $0.02
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
